Non-pharmaceutical intervention (epidemiology)
In epidemiology, a non-pharmaceutical intervention (NPI) is any method used to reduce the spread of an epidemic disease without requiring pharmaceutical drug treatments. Examples of non-pharmaceutical interventions that reduce the spread of infectious diseases include wearing a face mask and staying away from sick people.[1]
The US Centers for Disease Control and Prevention (CDC) points to personal, community, and environmental interventions.[2] NPIs have been recommended for pandemic influenza at both local[3] and global levels[4] and studied at large scale during the 2009 swine flu pandemic[5] and the COVID-19 pandemic.[6][7][8] NPIs are typically used in the period between the emergence of an epidemic disease and the deployment of an effective vaccine.[9]
Types
editChoosing to stay home to prevent the spread of symptoms of a potential sickness, covering coughs and sneezes, and washing one's hands regularly, are all examples of non-pharmaceutical interventions.[10] Another example is when administrators of schools, workplaces, community areas, etc., take proper preventive actions and remind people to take precautions when need be in order to avoid the spread of disease.[10] Most NPIs are simple, requiring little effort to put into practice, and, if implemented correctly, have the potential to save lives.
Personal protective measures
editHand hygiene
editRespiratory etiquette
editIn the past, suggestions have been made that covering the mouth and nose, like with an elbow, tissue, or hand, would be a viable measure towards reducing the transmissions of airborne diseases. This method of source control was suggested, but not empirically tested, in the "Control of Airborne Infection" section of a 1974 publication of Riley's Airborne Infection.[16] NIOSH also noted that the use of a tissue as source control, in their guidelines for TB, had not been tested as of 1992.[17]
In 2013, Gustavo et al. looked into the effectiveness of various methods of source control, including via the arm, via a tissue, via bare hands, and via a surgical mask. They concluded that simply covering a cough was not an effective method of stopping transmission, and a surgical mask was not effective at reducing the amount of displaced droplets detected compared to the other rudimentary forms of source control.[18] Another paper noted that the fit of a face mask matters in its source control performance.[19] (However, note that OSHA 29 CFR 1910.134 does not cover the fit of face masks other than NIOSH-approved respirators.[20])Face masks
editWhile source control protects others from transmission arising from the wearer, personal protective equipment protects the wearer themselves.[21] Cloth face masks can be used for source control (as a last resort) but are not considered personal protective equipment[22][21] as they have low filter efficiency (generally varying between 2–60%), although they are easy to obtain and reusable after washing.[23] There are no standards or regulation for self-made cloth face masks,[24] and source control on a well-fitted cloth mask is worse than a surgical mask.[25]
Surgical masks are designed to protect against splashes and sprays,[26] but do not provide complete respiratory protection from germs and other contaminants because of the loose fit between the surface of the face mask and the face.[27] Surgical masks are regulated by various national standards to have high bacterial filtration efficiency (BFE).[28][29][30] N95/N99/N100 masks and other filtering facepiece respirators can provide source control in addition to respiratory protection, but respirators with an unfiltered exhalation valve may not provide source control and require additional measures to filter exhalation air when source control is required.[26][31]Environmental measures
editSurface and object cleaning
editGerms can survive outside the body on hard surfaces for periods ranging from hours to weeks, depending on the virus and environmental conditions. The disinfection of high-touch surfaces with substances such as bleach or alcohol kills germs, preventing indirect contact transmission. Dirty surfaces should be washed before the use of disinfectant.[9][32]
Ultraviolet lights
editUltraviolet (UV) light can be used to destroy micro-organisms that exist in the environment. The installation of UV light fixtures can be costly and time consuming; it is unlikely that they could be used at the outbreak of an epidemic. There are possible health concerns involving UV light, as it may cause cancer and eye problems. The WHO does not recommend its use.[9]
Increased ventilation
editIncreased ventilation of a room through opening a window or through mechanized ventilation systems may reduce transmission within the room. Although opening a window may introduce allergens and air pollution, or, in some climates, cold air, it is overall a cheap and effective type of intervention, and its advantages probably outweigh its disadvantages.[9]
Modifying humidity
editViruses such as influenza and coronavirus thrive in cold, dry environments, and increasing the humidity of a room may reduce their transmission.[33] Higher humidity, however, may cause mold and mildew, which may in turn cause respiratory problems. Humidifiers are also expensive and will probably be in short supply at the start of an epidemic.[9]
Social distancing measures
editContact tracing
editIsolation of sick individuals
editQuarantine of exposed individuals
editQuarantine involves the voluntary or imposed confinement of potentially non-ill persons who have been exposed to an illness, regardless of whether they have contracted it. Quarantine will often happen at home, but it may happen elsewhere, such as aboard ships (maritime quarantine) or airlines (onboard quarantine). Like isolation of sick individuals, forced quarantine of exposed individuals brings with it ethical concerns, although in this case the concerns may be greater; quarantine involves restricting the movement of those who may otherwise be well, and in some cases may even cause them greater risk if they are quarantining with the sick person to whom they were exposed, such as a sick family member or roommate with whom they live. Like isolation, quarantine brings with it financial risk, because of work absenteeism.[9]
School measures and closures
editMeasures taken involving schools range from making changes to operations within schools to complete school closures. Lesser measures may involve reducing the density of students, such as by distancing desks, cancelling activities, reducing class sizes, or staggering class schedules. Sick students may be isolated from the greater student body, such as by having them stay at home or otherwise segregate them from other students.
More drastic measures include class dismissal, in which classes are cancelled but the school stays open to provide childcare to some children, and complete school closure. Both measures may be either reactive or proactive: In a reactive case, the measure takes place after an outbreak has occurred in the school; in a proactive case, the measure takes place in order to prevent spread within the community.
Closures of schools may affect the families of affected children, especially low-income families. Parents may be forced to miss work to care for their children, affecting financial stability; children may also miss out on free school meals, causing nutritional concerns. Long absences from schools because of closures can also have negative effects on students' education.[9]
However, in the months following the onset of the COVID-19 pandemic, instead of closures, remote learning was turned to as an intervention against infection by SARS-CoV-2 in the days before vaccines.[36]
Workplace measures and closures
editMeasures taken in the workplace include: remote work; paid leave; staggering shifts such that arrival, exit, and break times are different for each employee; reduced contact; and extended weekends.
Workplace closure is a more drastic measure. The financial effect of workplace closure on both the individual and the economy can be severe. When remote work is not possible, such as in essential services, businesses may not be able to comply with guidelines. In one simulation study school closure coupled with 50% absenteeism in the workplace would have had the highest financial impact of all the scenarios studied, although some studies have found that the combination would be effective in reducing both the attack rate and the height of an epidemic.
One benefit of workplace closure is that when used in conjunction with school closures they avoid the need for parents to make childcare arrangements for children who are staying away from school.
The WHO recommends workplace closure in the case of extraordinarily severe epidemics and pandemics.[9]
Avoiding crowding
editAvoiding crowding may involve: avoiding crowded areas such as shopping centres and transportation hubs; closing public spaces and banning large gatherings, such as sports events or religious activities; or setting a limit on small gatherings, such as limiting them to no more than a few people. There are negative consequences to the banning of gatherings; banning cultural or religious activities, for example, may prevent access to support in a time of crisis. Gatherings also allow sharing of information, which can provide comfort and reduce fear.
The WHO recommends this intervention in moderate and severe epidemics and pandemics.[9]
Travel-related measures
editTravel advice
editTravel advice involves notifying potential travelers that they may be entering a zone that is affected by a disease outbreak. It allows informed decisions to be made before travel, and it increases awareness when the traveler is in the destination country. Public awareness campaigns have been used in the past for areas affected by infectious diseases such as dengue, malaria, Middle East respiratory syndrome, and H1N1 influenza. Although such awareness campaigns may reduce exposure among those traveling abroad, they may cause economic impact, owing to reduced travel in countries about which the advice has been issued. Overall, this intervention type is considered both feasible and acceptable.[9]
Entry and exit screening
editEntry and exit screening involves screening travelers at ports of entry for symptoms of illness. Measures include: health declarations, in which travelers make a declaration that they have not recently had symptoms of illness; visual inspections of the traveler; and the use of non-contact thermography, in which a device such as a thermographic camera is used to measure the traveler's body temperature, in order to determine if they have a fever. Such a method may be circumvented by the traveler through the use of antipyretics before travel in order to reduce fever. More intensive measures such as molecular diagnostics and point-of-care rapid antigen detection tests may also be used, but they carry a high resource cost and may not be applicable to a large number of travelers. A substantial number of resources may be needed in order to train staff and acquire equipment.
Although there is probably no harm to the traveler by the use of this type of intervention, a limitation of it is that travelers may be asymptomatic on arrival and symptoms may not show until several days after entry, at which point they may have already exposed others to their illness. There are also ethical concerns involving invading the privacy of the traveler. Screening is considered by the WHO to be both acceptable and feasible, though they did not recommend its use in the case of influenza outbreak due to its inefficacy in identifying asymptomatic individuals.[9]
Internal travel restrictions
editTravel within a country may be restricted in order to delay the spread of disease. Restriction of travel within a country is likely to slow the spread of disease, but not prevent it entirely. Its use would be most effective at the start of a localized and extraordinarily severe pandemic for only a short period of time. It would only be effective if the measures were strict: while a 90% restriction was projected to delay spread by one or two weeks, a 75% restriction saw no effect. An analysis of the spread of influenza in America following complete airline closures due to the September 11 attacks saw reduced spread by 13 days compared with previous years.
Restricting travel brings both ethical, and in many countries, legal challenges. Freedom of movement is considered in many places to be a human right, and its restriction may have an adverse effect, particularly among vulnerable populations, such as migrant workers and those traveling to seek medical attention. Although 37% of the Member States of the WHO included internal travel restrictions as part of their pandemic preparedness plan as of 2019, some of those countries may face legal challenges in implementing them, because of their own laws. Such restrictions may also bring economic effects because of disruption in the supply chain.[9]
Border closure
editBorder closure is a measure that involves complete or severe restriction of travel across borders. This had a beneficial effect in delaying the spread of cases of influenza during the 1918 influenza pandemic, and was predicted to delay epidemic spread between Hong Kong and mainland China by 3.5 weeks. While border closure is expected to slow the spread of infection, it is not expected to reduce the duration of an epidemic. Strict border closure in island nations could be effective, although supply chain problems may cause adverse disruptions.
Supply chain problems due to border closure are likely to cause disruption of essential goods, such as food and medications, as well as serious economic effects. They may have adverse effects on the daily lives of individuals. Border closure also has serious ethical implications, because, like internal travel restrictions, it involves restricting the movements of individuals. It should only be used as a voluntary measure to the maximum extent possible. There may also be stigmatization of individuals from affected areas.
Border closure would be most feasible at the very start of a pandemic. The WHO recommended it only in extraordinary circumstances, and asked that they be notified by any nation implementing it.[9]
1918 influenza pandemic
editNon-pharmaceutical interventions were widely adopted during the 1918 flu outbreak – most famously, the radical quarantine of Gunnison, Colorado resulted in sparing the town the worst of the earlier waves of the pandemic.[1] Interventions used included the wearing of face masks, isolation, quarantine, personal hygiene, use of disinfectants, and limits on public gatherings. At the time, the science behind NPIs was new, and was not applied consistently in every area. Retroactive studies on the outbreak have shown that the measures were effective in mitigating the spread of the infection.[37][38]
The use of non-pharmaceutical interventions during the 1918 flu pandemic also gave rise to new societal concerns. There was a growing awareness of "overreacting" and "under-reacting" among U.S. public health authorities, and these opposing perspectives often added to the uncertainties inherent in the epidemic. Likewise, public perceptions varied with respect to adherence to public health guidelines, giving rise to terms such as "mask slackers" and "careless consumptives."[39]
COVID-19
editCOVID-19 is a disease caused by the SARS-CoV-2 virus, which spread from China, creating a pandemic.[40] Several COVID-19 vaccines are now being used, 6.54 billion doses having been administered worldwide as of 12 October 2021.[41]
In the early stages of the COVID-19 pandemic, before vaccines had been developed, NPIs were key in mitigating infections and reducing COVID-19-related mortality. Some NPIs remained in place or were reinstituted for a time after vaccine rollout.[42] One report identified over 500 specific NPIs for controlling transmission and spread of the SARS-CoV-2 virus; most of these have been tried in practice.[8] Evidence suggests that highly effective strategies include closing schools and universities,[43] banning large gatherings,[43] and wearing face masks.[44]
Engineering controls
editNPIs are still key to mitigating infections. NPIs, which include engineering controls under the Hierarchy of hazard controls, do not require compliance with PPE mandates, or require administrative changes, like lockdowns, to prevent the spread of disease among the general public.
The CDC suggests that, in non-healthcare settings, building ventilation should be brought up to 5 air changes per hour, along with the use of MERV-13 filters, the use of air purifiers (air cleaners), and upper-room Ultraviolet germicidal irradiation (UVGI) to reduce the odds of infection and people coming down with COVID-19.[45][46] The UVGI systems are said to be similar to the UVGI systems used against tuberculosis in the past in healthcare facilities.[47][46] As for ventilation, a survey conducted under 1989 ASHRAE standards showed that, of the buildings constructed in prior years and surveyed, all but one did not meet the recommended 5 ACH.[48]
Corsi–Rosenthal Boxes have been suggested as a viable temporary air cleaner. When tested by NIOSH, the boxes were found to reduce aerosols up to 73%, but most did not operate below noise standards.[49]Proposed controls
editThese fixtures have been suggested as forms of "engineering controls" in the Hierarchy of hazard controls:
- Instead of the use of UVGI, use of far-UVC lighting to inactivate the virus causing COVID-19.[50]
- Use of ceiling fans to aid in the removal of viral aerosols in the air, and support other engineering control measures, particularly ventilation.[51] One paper found that by using ceiling fans to mix the air, the particles involved in short-range transmission could drop significantly, at the cost of a small increase in the amount of particles involved in long-range transmission. However, for ceiling fans to be effective, the authors noted that occupancy in a given ventilated room should generally stay within ASHRAE 241 recommendations, at around 36-154 m3 ventilated air/hr/person.[52]
See also
editReferences
edit- ^ a b von Csefalvay C (2023), "Modeling the control of infectious disease", Computational Modeling of Infectious Disease, Elsevier, pp. 173–215, doi:10.1016/b978-0-32-395389-4.00015-3, ISBN 978-0-323-95389-4, retrieved 2023-03-05
- ^ "Nonpharmaceutical Interventions (NPIs) | CDC". www.cdc.gov. 2019-06-11. Retrieved 2020-04-16.
- ^ Bell D, Nicoll A, Fukuda K, Horby P, Monto A, Hayden F, et al. (January 2006). "Non-pharmaceutical interventions for pandemic influenza, national and community measures". Emerging Infectious Diseases. 12 (1): 88–94. doi:10.3201/eid1201.051371. PMC 3291415. PMID 16494723.
- ^ Bell D, Nicoll A, Fukuda K, Horby P, Monto A, Hayden F, et al. (January 2006). "Non-pharmaceutical interventions for pandemic influenza, international measures". Emerging Infectious Diseases. 12 (1): 81–7. doi:10.3201/eid1201.051370. PMC 3291414. PMID 16494722.
- ^ Mitchell T, Dee DL, Phares CR, Lipman HB, Gould LH, Kutty P, et al. (January 2011). "Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009". Clinical Infectious Diseases. 52 Suppl 1 (suppl_1): S138-45. doi:10.1093/cid/ciq056. PMID 21342886.
- ^ Imai N, Gaythorpe KA, Abbott S, Bhatia S, van Elsland S, Prem K, et al. (2020-04-02). "Adoption and impact of non-pharmaceutical interventions for COVID-19". Wellcome Open Research. 5: 59. doi:10.12688/wellcomeopenres.15808.1. PMC 7255913. PMID 32529040.
- ^ "Report 9 - Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand". Imperial College London. Retrieved 2020-04-16.
- ^ a b Sutherland WJ, et al. (2021). "A solution scan of societal options to reduce transmission and spread of respiratory viruses: SARS-CoV-2 as a case study". Journal of Biosafety and Biosecurity. 3 (2): 84–90. doi:10.1016/j.jobb.2021.08.003. PMC 8440234. PMID 34541465.
- ^ a b c d e f g h i j k l m Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza (PDF). World Health Organization. 2019. ISBN 978-92-4-151683-9. Archived (PDF) from the original on 2020-11-18. Retrieved 2020-11-25.
- ^ a b "Personal NPIs: Everyday Preventive Actions | Nonpharmaceutical Interventions | CDC". 26 August 2019.
- ^ "Show Me the Science – How to Wash Your Hands". www.cdc.gov. 2020-03-04. Retrieved 2020-03-06.
- ^ Huang C, Ma W, Stack S (August 2012). "The hygienic efficacy of different hand-drying methods: a review of the evidence". Mayo Clinic Proceedings. 87 (8): 791–8. doi:10.1016/j.mayocp.2012.02.019. PMC 3538484. PMID 22656243.
- ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020.
- ^ Centers for Disease Control (2 April 2020). "When and How to Wash Your Hands". cdc.gov.
- ^ Bloomfield SF, Aiello AE, Cookson B, O'Boyle C, Larson EL (December 2007). "The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including hand washing and alcohol-based hand sanitizers". American Journal of Infection Control. 35 (10): S27–S64. doi:10.1016/j.ajic.2007.07.001. PMC 7115270.
- ^ Riley RL (1974). "Airborne infection". The American Journal of Medicine. 57 (3): 466–475. doi:10.1016/0002-9343(74)90140-5. PMID 4212915.
- ^ NIOSH Recommended Guidelines for Personal Respiratory Protection of Workers in Health-care Facilities Potentially Exposed to Tuberculosis. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health. 1992. p. 12.
- ^ Zayas G, Chiang MC, Wong E, MacDonald F, Lange CF, Senthilselvan A, King M (2013). "Effectiveness of cough etiquette maneuvers in disrupting the chain of transmission of infectious respiratory diseases". BMC Public Health. 13: 811. doi:10.1186/1471-2458-13-811. PMC 3846148. PMID 24010919.
- ^ Lindsley WG, Blachere FM, Beezhold DH, Law BF, Derk RC, Hettick JM, Woodfork K, Goldsmith WT, Harris JR, Duling MG, Boutin B, Nurkiewicz T, Boots T, Coyle J, Noti JD (2021). "A comparison of performance metrics for cloth masks as source control devices for simulated cough and exhalation aerosols". Aerosol Science and Technology. 55 (10): 1125–1142. Bibcode:2021AerST..55.1125L. doi:10.1080/02786826.2021.1933377. PMC 9345405. PMID 35923216.
- ^ "1910.134 - Respiratory Protection". OSHA. Retrieved 2024-07-18.
- ^ a b "Meat and Poultry Processing Workers and Employers: Interim Guidance from CDC and the Occupational Safety and Health Administration (OSHA)". Centers for Disease Control and Prevention. 2020-05-12. At section "Cloth face coverings in meat and poultry processing facilities". Retrieved 2020-05-24.
- ^ "FAQs on the Emergency Use Authorization for Face Masks (Non-Surgical)". U.S. Food and Drug Administration. 2020-04-26. Retrieved 2020-05-21.
- ^ Rengasamy S, Eimer B, Shaffer RE (October 2010). "Simple respiratory protection--evaluation of the filtration performance of cloth masks and common fabric materials against 20-1000 nm size particles". The Annals of Occupational Hygiene. 54 (7). Oxford University Press: 789–798. doi:10.1093/annhyg/meq044. PMC 7314261. PMID 20584862.
The results showed that cloth masks and other fabric materials tested in the study had 40–90% instantaneous penetration levels against polydisperse NaCl aerosols employed in the National Institute for Occupational Safety and Health particulate respirator test protocol at 5.5 cm s−1.
- ^ "Community Respirators and Masks". NIOSH. 21 June 2023. Retrieved 2024-06-22.
- ^ Koh XQ, Sng A, Chee JY, Sadovoy A, Luo P, Daniel D (February 2022). "Outward and inward protection efficiencies of different mask designs for different respiratory activities". Journal of Aerosol Science. 160. Bibcode:2022JAerS.16005905K. doi:10.1016/j.jaerosci.2021.105905.
- ^ a b "Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings". U.S. Centers for Disease Control and Prevention. 2020-05-18. Retrieved 2020-05-21.
- ^ "N95 Respirators and Surgical Masks (Face Masks)". U.S. Food and Drug Administration. 2020-04-05. Retrieved 2020-05-23.
- ^ Robertson P (15 March 2020). "Comparison of Mask Standards, Ratings, and Filtration Effectiveness". Smart Air Filters.
- ^ 中华人民共和国医药行业标准:YY 0469–2011 医用外科口罩 (Surgical mask) (in Chinese)
- ^ 中华人民共和国医药行业标准:YY/T 0969–2013 一次性使用医用口罩 (Single-use medical face mask) Archived 2021-02-25 at the Wayback Machine (in Chinese)
- ^ Hazard JM, Cappa CD (June 2022). "Performance of Valved Respirators to Reduce Emission of Respiratory Particles Generated by Speaking". Environmental Science & Technology Letters. 9 (6): 557–560. Bibcode:2022EnSTL...9..557H. doi:10.1021/acs.estlett.2c00210. PMID 37552726.
- ^ "Coronavirus Disease 2019 (COVID-19) - Environmental Cleaning and Disinfection Recommendations". Centers for Disease Control and Prevention. 2020-02-11. Retrieved 2020-11-26.
- ^ Mecenas P, Bastos RT, Vallinoto AC, Normando D (2020-09-18). "Effects of temperature and humidity on the spread of COVID-19: A systematic review". PLOS ONE. 15 (9): e0238339. Bibcode:2020PLoSO..1538339M. doi:10.1371/journal.pone.0238339. PMC 7500589. PMID 32946453.
- ^ a b c d "Coronavirus disease (COVID-19): Contact tracing". www.who.int. Retrieved 2022-11-03.
- ^ a b c d e f Brandt AM (August 2022). "The History of Contact Tracing and the Future of Public Health". American Journal of Public Health. 112 (8): 1097–1099. doi:10.2105/AJPH.2022.306949. PMC 9342804. PMID 35830671.
- ^ Lieberman M (2020-07-22). "COVID-19 & Remote Learning: How to Make It Work". Education Week. ISSN 0277-4232. Retrieved 2024-07-24.
- ^ "The 1918 Flu Pandemic: Why It Matters 100 Years Later | Blogs | CDC". Centers for Disease Control and Infection. 14 May 2018. Archived from the original on 2021-12-23. Retrieved 2021-12-22.
- ^ Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, Cetron MS (2007-08-08). "Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic". JAMA. 298 (6): 644–654. doi:10.1001/jama.298.6.644. ISSN 0098-7484. PMID 17684187.
- ^ Tomes N (2010). ""Destroyer and Teacher": Managing the Masses During the 1918–1919 Influenza Pandemic". Public Health Reports. 125 (Suppl 3): 48–62. doi:10.1177/00333549101250S308. ISSN 0033-3549. PMC 2862334. PMID 20568568.
- ^ Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 92(6):577-583. 2020.
- ^ Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, Hasell J, MacDonald B, Beltekian D, Roser M (5 March 2020). "Coronavirus (COVID-19) Vaccinations – Statistics and Research". Our World in Data. Retrieved 12 October 2021.
- ^ Anon (25 June 2021). "Coronavirus: Israel reimposes masks amid new virus fears". BBC News. Retrieved 12 October 2021.
- ^ a b Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenčiak T, Stephenson AB, Leech G, Altman G, Mikulik V, Norman AJ, Monrad JT, Besiroglu T, Ge H, Hartwick MA, Teh YW, Chindelevitch L, Gal Y, Kulveit J (2021). "Inferring the effectiveness of government interventions against COVID-19". Science. 371 (6531). doi:10.1126/science.abd9338. hdl:10044/1/86864. ISSN 0036-8075. PMC 7877495. PMID 33323424.
- ^ Brooks JT, Butler JC (2021). "Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2". JAMA. 325 (10): 998–999. doi:10.1001/jama.2021.1505. ISSN 0098-7484. PMC 8892938. PMID 33566056. S2CID 231868838.
- ^ "Improving Ventilation In Buildings Error processing SSI file". www.cdc.gov. Retrieved 2024-07-24.
- ^ a b "Upper-Room Ultraviolet Germicidal Irradiation (UVGI)". www.cdc.gov. 2023-10-27. Retrieved 2024-07-24.
- ^ NIOSH Recommended Guidelines for Personal Respiratory Protection of Workers in Health-care Facilities Potentially Exposed to Tuberculosis. 1992.
- ^ Persily A. "VENTILATION RATES IN OFFICE BUILDINGS" (PDF). Retrieved 2024-07-24.
- ^ "The Effectiveness of DIY Air Filtration Units | Blogs | CDC". 2023-02-03. Retrieved 2024-07-24.
- ^ Bhardwaj SK, Singh H, Deep A, Khatri M, Bhaumik J, Kim KH, Bhardwaj N (2021-10-20). "UVC-based photoinactivation as an efficient tool to control the transmission of coronaviruses". Science of the Total Environment. 792: 148548. Bibcode:2021ScTEn.79248548B. doi:10.1016/j.scitotenv.2021.148548. ISSN 0048-9697. PMC 8238411. PMID 34465056.
- ^ Li W, Hasama T, Chong A, Hang JG, Lasternas B, Lam KP, Tham KW (2023-02-15). "Transient transmission of droplets and aerosols in a ventilation system with ceiling fans". Building and Environment. 230: 109988. Bibcode:2023BuEnv.23009988L. doi:10.1016/j.buildenv.2023.109988. ISSN 0360-1323.
- ^ Li J, Zuraimi S, Schiavon S (2024). "Should we use ceiling fans indoors to reduce the risk of transmission of infectious aerosols?". Indoor Environments. 1 (3). doi:10.1016/j.indenv.2024.100039.